alcohol glp-1 medications get at the heart of addiction: study – WashU Medicine GLP-1 receptor agonists for the
Description
Retatrutide Triple Agonist (GLP-1/GIP/GCG) for advanced metabolic research
GoodRx reports that while satisfaction with GLP-1s for weight loss is high, costs and access issues significantly impact patient experiences.
If you think it's just an occasional observation, think again
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.
Randomized controlled trials (RCTs) comparing insulin with established GLP-1 RAs, DPP-4is, or SGLT-2is were included
